206 related articles for article (PubMed ID: 37686552)
1. Thiazolidinedione Use Is Associated with a Borderline Lower Risk of Multiple Myeloma and a Significantly Lower Risk of Death in Patients with Type 2 Diabetes Mellitus in Taiwan.
Tseng CH
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686552
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis.
Tseng CH
BMC Cancer; 2022 May; 22(1):559. PubMed ID: 35585577
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis.
Tseng CH
J Clin Med; 2018 Sep; 7(10):. PubMed ID: 30262775
[TBL] [Abstract][Full Text] [Related]
4. Rosiglitazone Does Not Affect the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study in Taiwanese Type 2 Diabetes Patients.
Tseng CH
Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242462
[TBL] [Abstract][Full Text] [Related]
5. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus.
Tseng CH
Sci Rep; 2021 Jun; 11(1):12400. PubMed ID: 34117321
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone and Prostate Cancer Risk in Taiwanese Male Patients with Type 2 Diabetes: A Retrospective Cohort Study.
Tseng CH
World J Mens Health; 2023 Jan; 41(1):119-128. PubMed ID: 35274506
[TBL] [Abstract][Full Text] [Related]
7. Dementia Risk in Type 2 Diabetes Patients: Acarbose Use and Its Joint Effects with Metformin and Pioglitazone.
Tseng CH
Aging Dis; 2020 May; 11(3):658-667. PubMed ID: 32489710
[TBL] [Abstract][Full Text] [Related]
8. Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes.
Yen FS; Wei JC; Hung YT; Hsu CY; Hwu CM; Hsu CC
Front Microbiol; 2023; 14():1118000. PubMed ID: 36876083
[TBL] [Abstract][Full Text] [Related]
9. Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and cirrhosis.
Yen FS; Wei JC; Chiu LT; Hsu CC; Hou MC; Hwu CM
Liver Int; 2021 Jan; 41(1):110-122. PubMed ID: 33124143
[TBL] [Abstract][Full Text] [Related]
10. The Risk of Age-Related Macular Degeneration Is Reduced in Type 2 Diabetes Patients Who Use Metformin.
Tseng CH
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259372
[TBL] [Abstract][Full Text] [Related]
11. Liver-related long-term outcomes of thiazolidinedione use in persons with type 2 diabetes.
Yen FS; Yang YC; Hwu CM; Wei JC; Huang YH; Hou MC; Hsu CC
Liver Int; 2020 May; 40(5):1089-1097. PubMed ID: 31960563
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study.
Tseng CH
Int J Chron Obstruct Pulmon Dis; 2022; 17():285-295. PubMed ID: 35177899
[TBL] [Abstract][Full Text] [Related]
13. Metformin Use Is Associated With a Lower Incidence of Hospitalization for Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus.
Tseng CH
Front Med (Lausanne); 2020; 7():592901. PubMed ID: 33693008
[No Abstract] [Full Text] [Related]
14. Pioglitazone Has a Null Association with Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus.
Tseng CH
Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36558989
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone has a neutral effect on the risk of dementia in type 2 diabetes patients.
Tseng CH
Aging (Albany NY); 2019 May; 11(9):2724-2734. PubMed ID: 31085804
[TBL] [Abstract][Full Text] [Related]
16. Effect of Metformin on Lower Urinary Tract Symptoms in Male Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study in Taiwan.
Tseng CH
World J Mens Health; 2023 Jul; 41(3):680-691. PubMed ID: 36593711
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events.
Starner CI; Schafer JA; Heaton AH; Gleason PP
J Manag Care Pharm; 2008; 14(6):523-31. PubMed ID: 18693776
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease.
Yen FS; Wei JC; Yang YC; Hsu CC; Hwu CM
Front Med (Lausanne); 2021; 8():729518. PubMed ID: 34957135
[TBL] [Abstract][Full Text] [Related]
19. Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population.
Kalsekar I; Iyer S; Mody R; Rajagopalan R; Kavookjian J
J Manag Care Pharm; 2006 Mar; 12(2):121-9. PubMed ID: 16515370
[TBL] [Abstract][Full Text] [Related]
20. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]